Clusterin and Related Scoring Index as Potential Early Predictors of Response to Sorafenib in Hepatocellular Carcinoma

Advanced hepatocellular carcinoma (HCC) remains a highly lethal malignancy, although several systemic therapeutic options are available, including sorafenib (SFN), which has been one of the standard treatment agents for almost a decade. As early prediction of response to SFN remains challenging, bio...

Descripción completa

Detalles Bibliográficos
Autores principales: Narahara, Satoshi, Watanabe, Takehisa, Nagaoka, Katsuya, Fujimoto, Nahoko, Furuta, Yoki, Tanaka, Kentaro, Tokunaga, Takayuki, Kawasaki, Takeshi, Yoshimaru, Yoko, Setoyama, Hiroko, Oniki, Kentaro, Saruwatari, Junji, Tateyama, Masakuni, Naoe, Hideaki, Tanaka, Motohiko, Tanaka, Yasuhito, Sasaki, Yutaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035573/
https://www.ncbi.nlm.nih.gov/pubmed/34837478
http://dx.doi.org/10.1002/hep4.1872

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035573/
https://www.ncbi.nlm.nih.gov/pubmed/34837478
http://dx.doi.org/10.1002/hep4.1872

Ejemplares similares